{
 "dataset": "benzoyl-peroxide-trials",
 "source": "https://verifiedbeautydata.com/ingredients/benzoyl-peroxide/",
 "licence": "CC BY 4.0 — https://creativecommons.org/licenses/by/4.0/",
 "cite_as": "Verified Beauty Data, \"benzoyl peroxide: trials table\", https://verifiedbeautydata.com/data/gold/benzoyl-peroxide-trials.json",
 "row_count": 8,
 "rows": [
  {
   "trial": "Kawashima 2017, J Dermatol (PMID 28295516)",
   "arm": "Placebo",
   "outcome": "Inflammatory lesions reduced at 12 weeks (median %)",
   "value_pct": 41.7,
   "n": 609,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  },
  {
   "trial": "Kawashima 2017, J Dermatol (PMID 28295516)",
   "arm": "2.5%",
   "outcome": "Inflammatory lesions reduced at 12 weeks (median %)",
   "value_pct": 72.7,
   "n": 609,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  },
  {
   "trial": "Kawashima 2017, J Dermatol (PMID 28295516)",
   "arm": "5%",
   "outcome": "Inflammatory lesions reduced at 12 weeks (median %)",
   "value_pct": 75,
   "n": 609,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  },
  {
   "trial": "Kawashima 2017, J Dermatol (PMID 28295516)",
   "arm": "Placebo",
   "outcome": "Patients reporting any adverse event",
   "value_pct": null,
   "n": 609,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  },
  {
   "trial": "Kawashima 2017, J Dermatol (PMID 28295516)",
   "arm": "2.5%",
   "outcome": "Patients reporting any adverse event",
   "value_pct": 56.4,
   "n": 609,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  },
  {
   "trial": "Kawashima 2017, J Dermatol (PMID 28295516)",
   "arm": "5%",
   "outcome": "Patients reporting any adverse event",
   "value_pct": 58.8,
   "n": 609,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  },
  {
   "trial": "MaxClarity II (PMID 23545906)",
   "arm": "2.5% BPO + 0.5% SA system",
   "outcome": "total lesion reduction, mean %",
   "value_pct": 56.9,
   "n": null,
   "duration_weeks": 8,
   "url": "https://pubmed.ncbi.nlm.nih.gov/23545906/"
  },
  {
   "trial": "Kawashima 2017 (PMID 28295516)",
   "arm": "2.5% BPO",
   "outcome": "inflammatory lesion reduction, median %",
   "value_pct": 72.7,
   "n": null,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/28295516/"
  }
 ]
}